跳至主要内容
临床试验/NCT01913392
NCT01913392已完成不适用

Prospective, Clinical Study of the Effect of Bariatric Surgery, Laparoscopic Sleeve Gastrectomy, on the Pharmacokinetics of Immunosuppressive Drugs in the Morbidly Obese, Kidney Transplant Candidate

Maisonneuve-Rosemont Hospital1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2013年7月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
1
主要终点
changes in the pharmacokinetics of oral immunosuppressive medications due to bariatric surgery, comparing pre-bariatric surgery to 12 months post-operative

研究概览

简要总结

A prospective clinical trial will study the effects of laparoscopic sleeve gastrectomy in the potential renal transplant candidate who is denied acceptance due mainly to the morbid obesity.

详细描述

The remaining factor in determining the effectiveness of bariatric surgery in the transplant population will be to study the effect on the pharmacokinetics of immunosuppressive medication, height, weight, BMI, abdominal circumference, blood pressure, Hba1c , average daily insulin requirements, lipid profile, TSH, 24h urine creatinine clearance and the SF-36 Quality of life questionnaire.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adult (>18 years)
  • stage IV and V chronic renal disease (glomerular filtration rate < 30 ml/min,
  • body mass index (BMI) of greater than 40 kg/m2 or > 35 with at least one co-morbidity such as hypertension, dyslipidemia or diabetes

排除标准

  • medically unfit for surgical intervention
  • previous gastric or intestinal surgery
  • active gastric disease
  • pregnancy or lactation
  • known intolerance to tacrolimus or mycophenolic acid
  • awaiting potential multi-organ transplantation
  • active infection

结局指标

主要结局

changes in the pharmacokinetics of oral immunosuppressive medications due to bariatric surgery, comparing pre-bariatric surgery to 12 months post-operative

时间窗: pre-bariatric surgery and 1 year after surgery

Tacrolimus and Mycophenolate AUC 0-24h

degree of weight loss achieved after bariatric surgery in the chronic renal failure patient.

时间窗: baseline and every 3 months

weight, BMI and abdominal circumference measures

Evaluate the change in general quality of life score, SF-36

时间窗: Baseline and 1 year after bariatric surgery

comparison of the SF score between Baseline and month 3, Baseline and month 6 and Baseline and month 12

次要结局

  • evaluate changes to residual renal function in the pre-dialysis renal transplant candidate(at baseline versus month 12 post-bariatric surgery)
  • the incidence of complications post-bariatric surgery will be evaluated(1, 6 and 12 months post-bariatric surgery)
  • evaluate the change in the number and dose of medications required to treat co-morbidities including, hypertension, hyperlipidemia and diabetes mellitus(baseline and 12 month post-bariatric surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gabriel Chan, Md

Transplant and general surgeon

Maisonneuve-Rosemont Hospital

研究点 (1)

Loading locations...

相似试验

Effect of Laparoscopic Sleeve Gastrectomy in the... | 临床试验